Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maeve J Barlow
Observed names:
M A Barlow,
Maeve Barlow
Institutions:
Central and North West London NHS Foundation Trust,
University College London
Observed institutions:
Harvard University,
Central and North West London NHS Foundation Trust,
The Alfred Hospital,
Massachusetts General Hospital,
Mortimer Market Centre,
Alfred Health,
University College London
show all 7
ORCID:
0000-0003-1161-8335
Observed ORCID:
0000-0003-1161-8335
OpenAlex ID:
A5034655869
Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine
1989
·
V A Johnson
, B D Walker
, et al.
·
Antimicrobial Agents and Chemotherapy
·
69
Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice
2025
·
Flora Olcott
, Philip D Oddie
, et al.
·
Clinical Infectious Diseases
·
10
Impact of COVID-19 on people with non-functioning spleens in Australia
2024
·
Maeve Barlow
, Penelope Jones
, et al.
·
Journal of Infection and Public Health
·
2
Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV
2026
·
James Mason
, Manik Kohli
, et al.
·
AIDS
Show more works
View as search
Works count:
4
Citation count:
81
H-index:
2
I10-index:
2
Year
Topic
Type